Cancer immunotherapy, Vaccine, Immunocontraception.
Bio: Dr. G. P. Talwar is a medical researcher working in the area of vaccines and immunocontraception. He received BSc (Hons) and MSc (Tech) degrees from the University of Punjab, DSc from Sorbonne working at the Institut Pasteur, Paris and DSc (hc) from Bundhelkhand University .He was Alexander von Humboldt Postdoctoral Fellow at Tübingen, Stuttgart and Munchen. He joined as Associate Professor of Biochemistry in the newly created All India Institute of Medical Sciences (AIIMS), New Delhi and also worked there as Professor and Head.He was Head, ICMR-WHO Research and Training Centre in Immunology for India and South East Asia (1972–91). He was the first Director of the National Institute of Immunology (NII). He was Professor of Eminence and Senior Consultant, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi and Director Research, Talwar Research Foundation, New Delhi, India.
Title : A Vaccine endowed with Multiple Applications and a Polyherbal formulation for Reproductive Health of Women.
We developed a Vaccine based on a non-pathogenic cultivable microorganism, Mycobacterium indicus pranii, which has immunotherapeutic cum immunoprophylactic properties against leprosy and tuberculosis. It is a potent invigorator of immune responses and has found use as an adjuvant in a potential Birth Control Vaccine. Given intralesionally it heals remarkably ugly ano-genital warts , and has both preventive and therapeutic action against Sp2/O Myelomas.
Also developed is a Polyherbal formulation BASANT, which has inhibitory action on N.gonorrhea, Chlamydia trachomatis, Candida tropicalis, Candida albicans and Candida glabrata, besides HIV and HPV. Given along with 3 selected Probiotics, it cures 95% of cases of recurring vaginosis. An amazing action of BASANT is to eliminate HPV16 from infected cervical cells restoring normal Pap Smear.
Related Journals & Conferences :
International Biotechnology and Pharmaceutical Industry Forum